{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:36:39Z","timestamp":1789616199300,"version":"build-2803163510"},"reference-count":20,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,3,7]],"date-time":"2007-03-07T00:00:00Z","timestamp":1173225600000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2007,3]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Tuberculosis (TB) is a common opportunistic infection among HIV\u2010infected people, and rifampicin is an important drug for the treatment of TB. However, administration of rifampicin in combination with antiretroviral therapy, particularly protease inhibitors, is difficult because of drug\u2013drug interactions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We have performed a prospective study in three HIV\u2010infected patients with TB treated with a rifampicin\u2010containing regimen (rifampicin 600\u2003mg per day) and antiretroviral therapy including only nucleoside reverse transcriptase inhibitors (NRTIs) plus atazanavir 300\u2003mg once a day (qd) and ritonavir 100\u2003mg qd, to evaluate whether the inducing effect of rifampicin on the drug\u2010metabolizing enzyme cytochrome P450 (CYP) 3A4 could be overcome by the inhibitory effect of ritonavir. A complete pharmacokinetic evaluation of the steady\u2010state concentrations of atazanavir and ritonavir was performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In all three cases, more than 50% of the time the atazanavir level was below the minimum recommended trough plasma level (150\u2003ng\/mL according to current pharmacokinetic guidelines) to inhibit HIV wild\u2010type replication.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These results strongly indicate that the administration of rifampicin with a combination of atazanavir 300\u2003mg qd plus ritonavir 100\u2003mg qd must be avoided because subtherapeutic concentrations of atazanavir are produced.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2007.00442.x","type":"journal-article","created":{"date-parts":[[2007,3,7]],"date-time":"2007-03-07T19:19:42Z","timestamp":1173295182000},"page":"131-134","source":"Crossref","is-referenced-by-count":29,"title":["Pharmacokinetic interaction between rifampicin and ritonavir\u2010boosted atazanavir in HIV\u2010infected patients<sup>*<\/sup>"],"prefix":"10.1111","volume":"8","author":[{"given":"J","family":"Mallolas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Sarasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Nomdedeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"L\u00f3pez\u2010P\u00faa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JL","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JM","family":"Gatell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,3,7]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"291","article-title":"AIDS across Europe, 1994\u201398","volume":"356","author":"Mocroft A","year":"2000","journal-title":"the EuroSIDA Study"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200201040-00010"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116064"},{"key":"e_1_2_5_5_2","first-page":"985","article-title":"Rifampin and rifabutin drug interactions","volume":"162","author":"Finch CK","year":"2002","journal-title":"an update"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.128387"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI6663"},{"key":"e_1_2_5_8_2","first-page":"307","article-title":"Role of cytochrome P450 3A4 in human metabolism of MK\u2010639, a potent human immunodeficiency virus protease inhibitor","volume":"24","author":"Chiba M","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1269"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/313548"},{"key":"e_1_2_5_11_2","first-page":"185","article-title":"Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV\u2010infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors","volume":"49","author":"Centers for Disease Control and Prevention.","year":"2000","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_2_5_12_2","unstructured":"GrangeS SchutzM SchmittC RiekM Gaudeul\u2010EhrhartE.Unexpected hepatotoxicity observed in a healthly volunteer study on the effects of multiple dose rifampicin on the steady\u2010state pharmacokinetics of ritonavir\u2010boosted saquinavir and vice versa.6th International Workshop on Clinical Pharmacology of HIV Therapy. Quebec Canada April 2005 [Abstract 35]."},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.5.1553-1560.2004"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363160-00003"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00461-06"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(01)00172-4"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2004.02241.x"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.56.2.383"},{"key":"e_1_2_5_19_2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/135965350300800407","article-title":"Administration of indinavir and low\u2010dose ritonavir (800\/100\u2003mg twice daily) with food reduces nephrotoxic peak plasma levels of indinavir","volume":"8","author":"Aarnoutse RE","year":"2003","journal-title":"Antivir Ther"},{"key":"e_1_2_5_20_2","unstructured":"GotzkowskySK WeidlerJ TonkinJet al. Cytochrome P450 (CYP) 3A4 and 2D6 activities are decreased in HIV\u2010infected subjects.39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco CA Sept 1999 [Abstract 656]."},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241090-00004"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2007.00442.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2007.00442.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T02:18:34Z","timestamp":1696904314000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2007.00442.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["10.1111\/j.1468-1293.2007.00442.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2007.00442.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}